Gartisertib

N/A

Report date: 2024/07/03 11:12:24
NME

Base Information

Drug NameGartisertib
Drug Alias NameM-4344VX-803MSC2580591AVRT-1228692
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Inactive CompaniesUniversity Of Alabama At Birmingham
Active IndicationsSolid tumours
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A